PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

Clinical trial NCT00039871 · COMPLETED

Trial details

NCT number: NCT00039871
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis Hepatitis C, Chronic Fibrosis Liver Cirrhosis

Start date: 2002-05-01
Primary completion: 2007-09-01
Enrollment: 2333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.